A case report on CREST syndrome with acrodermatitis

Authors

  • Adithya S. L. Department of Pharm D, Ezhuthachan College of Pharmaceutical Sciences, Marayamuttom, Thiruvananthapuram, Kerala, India
  • Anfi D. P. Department of Pharm D, Ezhuthachan College of Pharmaceutical Sciences, Marayamuttom, Thiruvananthapuram, Kerala, India
  • Shaiju S. Dharan Department of Pharmacy Practice, Ezhuthachan College of Pharmaceutical Sciences, Marayamuttom, Thiruvananthapuram, Kerala, India
  • Dhanya Dharman Department of Pharmacy Practice, Ezhuthachan College of Pharmaceutical Sciences, Marayamuttom, Thiruvananthapuram, Kerala, India

DOI:

https://doi.org/10.18203/2349-3291.ijcp20241687

Keywords:

CREST syndrome, AE, Dermatoses, RP, ANA IF, OGD

Abstract

Acrodermatitis enteropathica (AE) is an autosomal recessive disorder, which is characterized by mutation affecting intestinal zinc absorption, subsequently leading to hypozincemia. In 20% of the cases, occurs the triad comprising dermatitis, alopecia and intractable diarrhoea as its diagnostic hallmark. The major manifestations include dermatitis, diarrhoea, alopecia, mood changes, anorexia, neurological disturbances, growth retardation, weight loss and recurrent infections. It is caused by mutations in the gene that encodes a membrane protein that binds zinc. Zinc is an essential coenzyme in metal enzymes (like ALP), which is important structural component of gene regulatory proteins and gene expression. Calcinosis, Raynaud phenomenon, esophageal dysmotility, sclerodactyly, and telangiectasia (CREST) syndrome is a variant systemic sclerosis characterized by the presence of calcinosis, Raynaud’s phenomenon, oesophageal motility abnormalities, sclerodactyly and telangiectasia antinuclear antibodies recognizing chromosomal centromere proteins are characteristic of CREST syndrome and are present in more than 50% cases. Circulating antibodies against anti-nucleolar antigens are present in most patients with systemic scleroderma. Alterations of the blood vessels and induction of fibroblasts by potent mediators plays an important role in the early phase of scleroderma. Here, we present a case of 12-year-old girl child with insidious onset gradually progressive symptoms of dryness in both lower limbs, bluish discoloration of the fingers on exposure to cold, skin tightening over the face and hands, whitish pigmentation over the scalp and neck, whitish nodules progressing to ulceration over the posterior aspects of both elbows and difficulty in eating- both solids and liquids for 1-year duration.

References

Fritzler MJ, Kinsella TD, Garbutt E. The CREST syndrome: a distinct serological entry with anticentromere antibodies. Am J Med. 1980;69(4):520-6.

Sehgal VN, Jain S. Acrodermatitis Enteropathica. Clin Dermatol. 2000;18(6):745-8.

Tajalli M, Qureshi AA. Successful treatment of calcinosis cutis of fingertip in the setting of CREST syndrome with topical 20% sodium thiosulfate. JAAD Case Rep. 2019;5(11):9880-90.

Bakst R, Merola JK1, Franks Jr AG, Sanchez M. Raynaud’s phenomenon: pathogenesis and management. J Am Acad Dermatol. 2008;59(4):633-53.

Koenig M, Joyal F, Fritzler MJ, Roussin A, Abrahamowicz M, Boire G, et al. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud’s phenomenon to systemic sclerosis: a twenty-year prospective study of 5586 patients, with validation of proposed criteria for early systemic sclerosis. Arthritis Rheumatism. 2008;58(12):3902-12.

Maverakis E, Lynch PJ, Fazel N. Acrodermatitis enteropathica. Dermatol Online J. 2007;13(3):1-8.

Downloads

Published

2024-06-26

Issue

Section

Case Reports